Colgate-Palmolive Q4 Earnings: EPS of $0.90 Beats Estimates, Revenue of $4,944 Million Misses Expectations

GuruFocus
01-31

On January 31, 2025, Colgate-Palmolive Co (CL, Financial) released its 8-K filing detailing the financial results for the fourth quarter and full year of 2024. The company, a leader in the household and personal care industry, reported a mixed performance with a slight decline in quarterly net sales but a significant increase in annual earnings per share (EPS).

Company Overview

Founded in 1806, Colgate-Palmolive has established itself as a dominant force in the household and personal care sectors. The company is renowned for its oral care products, which contribute to over 40% of its total sales. Colgate-Palmolive's diverse product range, including shampoos, shower gels, deodorants, and homecare products, is available in more than 200 countries. Notably, international sales constitute approximately 70% of its business, with 45% stemming from emerging markets. Additionally, the company owns Hill's, a specialty pet food maker, accounting for about one-fifth of its sales.

Performance Highlights and Challenges

For the full year 2024, Colgate-Palmolive achieved a milestone by surpassing $20 billion in net sales, marking a 3.3% increase from the previous year. Organic sales grew by 7.4%, despite a 0.5% negative impact from lower private label pet volume. The company's GAAP EPS rose by 27% to $3.51, exceeding the annual estimate of $3.50. However, the fourth quarter presented challenges, with net sales slightly declining by 0.1% to $4,944 million, missing the quarterly revenue estimate of $4,980.23 million. Despite this, the quarterly GAAP EPS increased by 3% to $0.90, surpassing the estimated $0.89.

Financial Achievements and Industry Significance

Colgate-Palmolive's financial achievements underscore its resilience and strategic positioning in the consumer packaged goods industry. The company's ability to grow organic sales across all divisions and categories for the sixth consecutive year highlights its robust market presence. The increase in gross profit margin by 70 basis points to 60.3% in the fourth quarter reflects effective cost management and pricing strategies, crucial for maintaining competitiveness in a challenging economic environment.

Key Financial Metrics

The company's full-year net cash provided by operations was $4,107 million, a 10% increase from 2023, enabling it to return $3.4 billion to shareholders through dividends and share repurchases. The effective tax rate improved to 22.9% from 27.6% in the previous year, contributing to the enhanced net income of $2,889 million, up from $2,300 million in 2023.

Metric 2024 2023 Change
Net Sales (Annual) $20,101 million $19,457 million +3.3%
EPS (Annual, GAAP) $3.51 $2.77 +27%
Net Sales (Q4) $4,944 million $4,950 million -0.1%
EPS (Q4, GAAP) $0.90 $0.87 +3%

Analysis and Commentary

Colgate-Palmolive's performance in 2024 demonstrates its strategic agility and commitment to growth, despite macroeconomic headwinds. The company's focus on organic sales growth and operational efficiency has yielded positive results, as evidenced by the improved profit margins and EPS. However, the slight decline in fourth-quarter net sales indicates potential challenges in maintaining momentum, particularly in the face of foreign exchange impacts and competitive pressures.

Noel Wallace, Chairman, President, and CEO, remarked, "We are pleased to have delivered another quarter and full year of strong organic sales growth along with increases in gross profit, gross profit margin, net income, earnings per share, and cash flow. Our goals for 2024 were to deliver peer-leading growth while funding investment for future growth and building flexibility into our P&L to counter macro headwinds."

Overall, Colgate-Palmolive's strategic initiatives and financial discipline position it well for continued success in the consumer packaged goods sector, with a focus on innovation and market expansion.

Explore the complete 8-K earnings release (here) from Colgate-Palmolive Co for further details.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10